Invest now
Concord Drugs Cash Flow Annual
BSE: 538965 | NSE: - | ISIN: INE858L01010 | Sector: Biotechnology & Drugs70.40 -0.60 (-0.85%)Updated : 09 Oct 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | -4.61 | 0.60 | 0.46 | -0.19 |
| Net Changein Cash | 0.16 | -0.02 | 0.07 | 0.02 |
| Cash Taxes Paid | 0.42 | 0.20 | 0.22 | 0.38 |
| Net Income/ Starting Line | 1.47 | 0.69 | 0.63 | 1.25 |
| Changesin Working Capital | -10.27 | -0.41 | -3.25 | -2.84 |
| Cashfrom Operating Activities | -5.75 | 3.72 | 0.79 | 1.66 |
| Cash Interest Paid | 1.62 | 2.03 | 1.87 | 1.64 |
| Cashfrom Financing Activities | 7.04 | -1.43 | 0.28 | 0.62 |
| Issuance( Retirement)of Stock Net | 3.18 | 0.00 | 0.68 | 1.89 |
| Depreciation/ Depletion | 1.37 | 1.43 | 1.56 | 1.63 |
| Other Investing Cash Flow Items Total | 0.03 | 0.01 | 0.01 | -1.41 |
| Capital Expenditures | -1.17 | -2.33 | -1.02 | -0.86 |
| period Type | - | - | - | - |
| Non- Cash Items | 1.68 | 2.01 | 1.86 | 1.63 |
| Financing Cash Flow Items | 8.47 | -2.03 | -0.86 | -1.07 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -1.13 | -2.32 | -1.01 | -2.27 |
*All figures in crores except per share values
Concord Drugs Quick Links
Concord Drugs Dividend Concord Drugs Bonus Concord Drugs News Concord Drugs AGM Concord Drugs Rights Concord Drugs Splits Concord Drugs Board Meetings Concord Drugs Key Metrics Concord Drugs Shareholdings Concord Drugs Profit Loss Concord Drugs Balance Sheet Concord Drugs Q1 Results Concord Drugs Q2 Results Concord Drugs Q3 Results Concord Drugs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,035.00+40.00(4.02%)
2,079.30+29.30(1.43%)
1,246.00+17.00(1.38%)
11,400.00-549.00 (-4.59%)
2,851.05-96.35 (-3.27%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.